Melanie Paff
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Hepatitis B Virus Studies, Hepatitis C virus research, Animal Virus Infections Studies, Liver Disease Diagnosis and Treatment, Influenza Virus Research Studies
Most-Cited Works
- → The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine(1992)234 cited
- → Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection(2022)234 cited
- → Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial(2021)144 cited
- 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.(1995)
- → In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks(1997)52 cited
- → Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells(1994)51 cited
- → High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells(2000)51 cited
- → Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol(1995)51 cited
- → Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy(2022)51 cited
- → Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B(2024)41 cited